• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Delivering on the promise of early detection with liquid biopsies.通过液体活检实现早期检测的承诺。
Br J Cancer. 2022 Feb;126(3):313-315. doi: 10.1038/s41416-021-01646-w. Epub 2022 Jan 10.
2
[Liquid biopsy: a possible approach for cancer screening].[液体活检:一种癌症筛查的可能方法]
Med Sci (Paris). 2018 Oct;34(10):824-832. doi: 10.1051/medsci/2018208. Epub 2018 Nov 19.
3
Utilising extracellular vesicles for early cancer diagnostics: benefits, challenges and recommendations for the future.利用细胞外囊泡进行早期癌症诊断:未来的益处、挑战和建议。
Br J Cancer. 2022 Feb;126(3):323-330. doi: 10.1038/s41416-021-01668-4. Epub 2022 Jan 10.
4
Application of liquid biopsy as multi-functional biomarkers in head and neck cancer.液体活检在头颈部癌症中作为多功能生物标志物的应用。
Br J Cancer. 2022 Feb;126(3):361-370. doi: 10.1038/s41416-021-01626-0. Epub 2021 Dec 7.
5
Potential of circulating biomarkers in liquid biopsy diagnostics.循环生物标志物在液体活检诊断中的潜力。
Biotechniques. 2018 Oct;65(4):187-189. doi: 10.2144/btn-2018-0093.
6
Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine.液体活检在精准医学中的应用前景与挑战
Cancer Res. 2019 Jun 1;79(11):2798-2804. doi: 10.1158/0008-5472.CAN-18-3402. Epub 2019 May 20.
7
Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research.细胞外囊泡作为液体活检中前列腺癌生物标志物的来源:十年研究
Br J Cancer. 2022 Feb;126(3):331-350. doi: 10.1038/s41416-021-01610-8. Epub 2021 Nov 22.
8
Liquid biopsy for cancer diagnosis and screening - The promise and challenges.用于癌症诊断和筛查的液体活检——前景与挑战
Ann Clin Biochem. 2019 Jul;56(4):420-423. doi: 10.1177/0004563219837592. Epub 2019 Apr 11.
9
Liquid biopsy analysis in cancer diagnostics.癌症诊断中的液体活检分析
Mol Aspects Med. 2020 Apr;72:100839. doi: 10.1016/j.mam.2019.100839. Epub 2019 Dec 26.
10
Liquid biopsy for lung cancer screening: Usefulness of circulating tumor cells and other circulating blood biomarkers.液体活检在肺癌筛查中的应用:循环肿瘤细胞和其他循环血液生物标志物的作用。
Cancer Cytopathol. 2021 May;129(5):341-346. doi: 10.1002/cncy.22367. Epub 2020 Oct 2.

引用本文的文献

1
Advancements in DNA methylation technologies and their application in cancer diagnosis.DNA甲基化技术的进展及其在癌症诊断中的应用。
Epigenetics. 2025 Dec;20(1):2539995. doi: 10.1080/15592294.2025.2539995. Epub 2025 Jul 28.
2
Unsupervised detection of rare events in liquid biopsy assays.液体活检分析中罕见事件的无监督检测。
NPJ Precis Oncol. 2025 Jul 5;9(1):225. doi: 10.1038/s41698-025-01015-3.
3
Effectiveness of early cancer screening and diagnosis in urban China.中国城市早期癌症筛查与诊断的有效性
Sci Rep. 2025 Jul 2;15(1):23160. doi: 10.1038/s41598-025-05020-1.
4
Liquid Biopsy for Medical Imaging Analysis in Cancer Diagnosis.用于癌症诊断中医学影像分析的液体活检
Curr Pharm Des. 2025;31(33):2635-2650. doi: 10.2174/0113816128371883250310174153.
5
Unsupervised Detection of Rare Events in Liquid Biopsy Assays.液体活检分析中罕见事件的无监督检测。
bioRxiv. 2025 Jan 31:2025.01.29.635501. doi: 10.1101/2025.01.29.635501.
6
Doing 'detective work' to find a cancer: how are non-specific symptom pathways for cancer investigation organised, and what are the implications for safety and quality of care? A multisite qualitative approach.开展“侦查工作”以发现癌症:癌症调查的非特异性症状途径是如何组织的,以及对医疗安全和质量有何影响?一种多地点定性研究方法。
BMJ Qual Saf. 2025 Jun 19;34(7):457-468. doi: 10.1136/bmjqs-2024-017749.
7
Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management.评估血清肿瘤标志物癌胚抗原(CEA)、糖类抗原125(CA-125)和糖类抗原19-9(CA19-9)在非小细胞肺癌管理中的辅助作用。
Oncotarget. 2024 Jun 13;15:381-388. doi: 10.18632/oncotarget.28566.
8
Novel non-invasive molecular signatures for oral cavity cancer, by whole transcriptome and small non-coding RNA sequencing analyses: Predicted association with PI3K/AKT/mTOR pathway.通过全转录组和小非编码 RNA 测序分析鉴定口腔癌新型无创分子标志物:与 PI3K/AKT/mTOR 通路的预测关联。
Cancer Med. 2024 Jun;13(11):e7309. doi: 10.1002/cam4.7309.
9
The emerging roles of miRNA-mediated autophagy in ovarian cancer.微小RNA介导的自噬在卵巢癌中的新作用
Cell Death Dis. 2024 May 3;15(5):314. doi: 10.1038/s41419-024-06677-8.
10
Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer.精准医学时代液体活检的诊断价值:癌症领域10年临床证据
Explor Target Antitumor Ther. 2023;4(1):102-138. doi: 10.37349/etat.2023.00125. Epub 2023 Feb 28.

通过液体活检实现早期检测的承诺。

Delivering on the promise of early detection with liquid biopsies.

机构信息

Prevention and Early Detection Research, Cancer Research UK, London, UK.

出版信息

Br J Cancer. 2022 Feb;126(3):313-315. doi: 10.1038/s41416-021-01646-w. Epub 2022 Jan 10.

DOI:10.1038/s41416-021-01646-w
PMID:35013576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8811021/
Abstract

Liquid biopsy approaches are relatively well developed for cancer therapy monitoring and disease relapse, but they also have incredible potential in the cancer early detection and screening field. There are, however, several challenges to overcome before this potential can be met. Research in this area needs to be cohesive and, as a driver of research, Cancer Research UK is in an ideal position to enable this.

摘要

液体活检方法在癌症治疗监测和疾病复发方面已经相对成熟,但它们在癌症早期检测和筛查领域也具有巨大的潜力。然而,在实现这一潜力之前,还有一些挑战需要克服。这一领域的研究需要具有凝聚力,而英国癌症研究中心作为研究的推动者,非常适合推动这一领域的研究。